A platinum complex that binds non-covalently to DNA and induces cell death via a different mechanism than cisplatin
Cisplatin and some of its derivatives have been shown to be very successful anticancer agents. Their main mode of action has been proposed to be via covalent binding to DNA. However, one of the limitations of these drugs is their poor activity against some tumours due to intrinsic or acquired resist...
Saved in:
| Published in: | Metallomics Vol. 5; no. 5; p. 514 |
|---|---|
| Main Authors: | , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
01.05.2013
|
| Subjects: | |
| ISSN: | 1756-591X, 1756-591X |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Cisplatin and some of its derivatives have been shown to be very successful anticancer agents. Their main mode of action has been proposed to be via covalent binding to DNA. However, one of the limitations of these drugs is their poor activity against some tumours due to intrinsic or acquired resistance. Therefore, there is interest in developing complexes with different binding modes and mode of action. Herein we present a novel platinum(ii)-terpyridine complex (1) which interacts non-covalently with DNA and induces cell death via a different mechanism than cisplatin. The interaction of this complex with DNA was studied by UV/Vis spectroscopic titrations, fluorescent indicator displacement (FID) assays and circular dichroism (CD) titrations. In addition, computational docking studies were carried out with the aim of establishing the complex's binding mode. These experimental and computational studies showed the complex to have an affinity constant for DNA of ∼10(4) M(-1), a theoretical free energy of binding of -10.83 kcal mol(-1) and selectivity for the minor groove of DNA. Long-term studies indicated that 1 did not covalently bind (or nick) DNA. The cancer cell antiproliferative properties of this platinum(ii) complex were probed in vitro against human and murine cell lines. Encouragingly the platinum(ii) complex displayed selective toxicity for the cancerous (U2OS and SH-SY5Y) and proliferating NIH 3T3 cell lines. Further cell based studies were carried out to establish the mode of action. Cellular uptake studies demonstrated that the complex is able to penetrate the cell membrane and localize to the nucleus, implying that genomic DNA could be a cellular target. Detailed immunoblotting studies in combination with DNA-flow cytometry showed that the platinum(ii) complex induced cell death in a manner consistent with necrosis. |
|---|---|
| AbstractList | Cisplatin and some of its derivatives have been shown to be very successful anticancer agents. Their main mode of action has been proposed to be via covalent binding to DNA. However, one of the limitations of these drugs is their poor activity against some tumours due to intrinsic or acquired resistance. Therefore, there is interest in developing complexes with different binding modes and mode of action. Herein we present a novel platinum(ii)-terpyridine complex (1) which interacts non-covalently with DNA and induces cell death via a different mechanism than cisplatin. The interaction of this complex with DNA was studied by UV/Vis spectroscopic titrations, fluorescent indicator displacement (FID) assays and circular dichroism (CD) titrations. In addition, computational docking studies were carried out with the aim of establishing the complex's binding mode. These experimental and computational studies showed the complex to have an affinity constant for DNA of ∼10(4) M(-1), a theoretical free energy of binding of -10.83 kcal mol(-1) and selectivity for the minor groove of DNA. Long-term studies indicated that 1 did not covalently bind (or nick) DNA. The cancer cell antiproliferative properties of this platinum(ii) complex were probed in vitro against human and murine cell lines. Encouragingly the platinum(ii) complex displayed selective toxicity for the cancerous (U2OS and SH-SY5Y) and proliferating NIH 3T3 cell lines. Further cell based studies were carried out to establish the mode of action. Cellular uptake studies demonstrated that the complex is able to penetrate the cell membrane and localize to the nucleus, implying that genomic DNA could be a cellular target. Detailed immunoblotting studies in combination with DNA-flow cytometry showed that the platinum(ii) complex induced cell death in a manner consistent with necrosis. Cisplatin and some of its derivatives have been shown to be very successful anticancer agents. Their main mode of action has been proposed to be via covalent binding to DNA. However, one of the limitations of these drugs is their poor activity against some tumours due to intrinsic or acquired resistance. Therefore, there is interest in developing complexes with different binding modes and mode of action. Herein we present a novel platinum(ii)-terpyridine complex (1) which interacts non-covalently with DNA and induces cell death via a different mechanism than cisplatin. The interaction of this complex with DNA was studied by UV/Vis spectroscopic titrations, fluorescent indicator displacement (FID) assays and circular dichroism (CD) titrations. In addition, computational docking studies were carried out with the aim of establishing the complex's binding mode. These experimental and computational studies showed the complex to have an affinity constant for DNA of ∼10(4) M(-1), a theoretical free energy of binding of -10.83 kcal mol(-1) and selectivity for the minor groove of DNA. Long-term studies indicated that 1 did not covalently bind (or nick) DNA. The cancer cell antiproliferative properties of this platinum(ii) complex were probed in vitro against human and murine cell lines. Encouragingly the platinum(ii) complex displayed selective toxicity for the cancerous (U2OS and SH-SY5Y) and proliferating NIH 3T3 cell lines. Further cell based studies were carried out to establish the mode of action. Cellular uptake studies demonstrated that the complex is able to penetrate the cell membrane and localize to the nucleus, implying that genomic DNA could be a cellular target. Detailed immunoblotting studies in combination with DNA-flow cytometry showed that the platinum(ii) complex induced cell death in a manner consistent with necrosis.Cisplatin and some of its derivatives have been shown to be very successful anticancer agents. Their main mode of action has been proposed to be via covalent binding to DNA. However, one of the limitations of these drugs is their poor activity against some tumours due to intrinsic or acquired resistance. Therefore, there is interest in developing complexes with different binding modes and mode of action. Herein we present a novel platinum(ii)-terpyridine complex (1) which interacts non-covalently with DNA and induces cell death via a different mechanism than cisplatin. The interaction of this complex with DNA was studied by UV/Vis spectroscopic titrations, fluorescent indicator displacement (FID) assays and circular dichroism (CD) titrations. In addition, computational docking studies were carried out with the aim of establishing the complex's binding mode. These experimental and computational studies showed the complex to have an affinity constant for DNA of ∼10(4) M(-1), a theoretical free energy of binding of -10.83 kcal mol(-1) and selectivity for the minor groove of DNA. Long-term studies indicated that 1 did not covalently bind (or nick) DNA. The cancer cell antiproliferative properties of this platinum(ii) complex were probed in vitro against human and murine cell lines. Encouragingly the platinum(ii) complex displayed selective toxicity for the cancerous (U2OS and SH-SY5Y) and proliferating NIH 3T3 cell lines. Further cell based studies were carried out to establish the mode of action. Cellular uptake studies demonstrated that the complex is able to penetrate the cell membrane and localize to the nucleus, implying that genomic DNA could be a cellular target. Detailed immunoblotting studies in combination with DNA-flow cytometry showed that the platinum(ii) complex induced cell death in a manner consistent with necrosis. |
| Author | Mendoza, Oscar Duarte, Alexandra A Suntharalingam, Kogularamanan Mann, David J Vilar, Ramon |
| Author_xml | – sequence: 1 givenname: Kogularamanan surname: Suntharalingam fullname: Suntharalingam, Kogularamanan organization: Department of Chemistry, Imperial College London, London SW7 2AZ, UK – sequence: 2 givenname: Oscar surname: Mendoza fullname: Mendoza, Oscar – sequence: 3 givenname: Alexandra A surname: Duarte fullname: Duarte, Alexandra A – sequence: 4 givenname: David J surname: Mann fullname: Mann, David J – sequence: 5 givenname: Ramon surname: Vilar fullname: Vilar, Ramon |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23487034$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkElPwzAUhC1URBe48APQO3IJeMt2rEpZpAouPXCLbMdWjWInxE5F_z2pWiROM9L7NPM0czTxrdcI3RL8QDArHxVzkWKaUnOBZiRPsyQtyefkn5-ieQhfGGcc4_QKTSnjRY4Zn6GwhK4R0frBgWpd1-gfiDsRQVpfBxibEtXuRaN9bA4QW3h6X4LwNYznQekASjcN1FrEHeytAAG1NUb3Iw9Oq53wNrhjogdlw6nqGl0a0QR9c9YF2j6vt6vXZPPx8rZabhLFKIsJITIlhsmCYimkKaXkmdQZ5ZLxnHKSimwUXkhe5hljhaGUZqURklBJMacLdH-K7fr2e9AhVs6G47vC63YIFRlHSI-bkBG9O6ODdLquut460R-qv53oL6-9a0o |
| CitedBy_id | crossref_primary_10_1002_jccs_201500169 crossref_primary_10_3390_ph16010125 crossref_primary_10_1016_j_ccr_2024_215666 crossref_primary_10_1016_j_nano_2019_04_001 crossref_primary_10_1039_D2NR05403E crossref_primary_10_1016_j_saa_2015_05_095 crossref_primary_10_1016_j_saa_2021_120096 crossref_primary_10_1016_j_molliq_2017_09_104 crossref_primary_10_1016_j_ica_2024_121981 crossref_primary_10_1016_j_jinorgbio_2019_110868 crossref_primary_10_1016_j_ejmech_2018_07_055 crossref_primary_10_1016_j_jinorgbio_2015_11_026 crossref_primary_10_1016_j_jinorgbio_2016_06_009 crossref_primary_10_1016_j_bej_2019_05_007 crossref_primary_10_1007_s12039_015_1003_y crossref_primary_10_1016_j_ica_2017_09_010 crossref_primary_10_1002_slct_201800961 crossref_primary_10_1016_j_molliq_2017_10_100 crossref_primary_10_1016_j_ejmech_2024_117077 crossref_primary_10_1039_D4QI02098G crossref_primary_10_1002_ejic_201501458 crossref_primary_10_1007_s10534_024_00646_6 crossref_primary_10_1016_j_jinorgbio_2020_111064 crossref_primary_10_1016_j_poly_2020_114502 crossref_primary_10_1002_aoc_3680 crossref_primary_10_1016_j_bmc_2017_04_035 crossref_primary_10_1080_07391102_2022_2090440 crossref_primary_10_3390_nano11092154 crossref_primary_10_1016_j_saa_2018_05_073 crossref_primary_10_1002_qua_26525 crossref_primary_10_1016_j_jinorgbio_2014_10_003 crossref_primary_10_1016_j_ejmech_2014_10_055 crossref_primary_10_1002_chem_201503663 crossref_primary_10_1039_c3mt00225j crossref_primary_10_1111_cbdd_13332 crossref_primary_10_1016_j_inoche_2018_06_013 crossref_primary_10_1002_slct_202004153 crossref_primary_10_1021_acs_jmedchem_5c00543 crossref_primary_10_1002_chem_201405991 crossref_primary_10_1002_cmdc_202400196 crossref_primary_10_3390_molecules25153492 crossref_primary_10_1016_j_jinorgbio_2017_02_002 crossref_primary_10_1039_C7QI00299H crossref_primary_10_1016_j_cbi_2017_09_011 crossref_primary_10_1016_j_ejmech_2014_05_060 crossref_primary_10_1002_pola_27290 crossref_primary_10_1007_s00011_019_01258_4 crossref_primary_10_1039_C7QI00346C crossref_primary_10_1016_j_molliq_2021_116290 crossref_primary_10_1021_jacs_8b09999 crossref_primary_10_1016_j_jrras_2022_01_017 crossref_primary_10_1016_j_ijbiomac_2016_11_022 crossref_primary_10_3390_inorganics7020013 crossref_primary_10_1016_j_inoche_2021_108571 crossref_primary_10_2217_nnm_2018_0259 crossref_primary_10_1016_j_colsurfb_2017_05_037 crossref_primary_10_1016_j_ccr_2015_11_004 crossref_primary_10_1155_2018_8759372 crossref_primary_10_1002_cbic_201800638 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1039/c3mt20252f |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Anatomy & Physiology |
| EISSN | 1756-591X |
| ExternalDocumentID | 23487034 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- 0-7 0R~ 123 29M 4.4 53G 5WD 705 7~J AAEMU AAIWI AAJAE AANOJ AAPXW AARHZ AAUAY AAVAP AAWGC ABDFA ABDVN ABEJV ABEMK ABGNP ABJNI ABMNT ABPQP ABPTD ABRYZ ABVGC ABWST ABXOH ABXVV ABXZS ACGFS ACIWK ACLDK ACPRK ACRPL ADGKP ADIPN ADMRA ADNBA ADNMO ADQBN ADSRN ADVEK AEFDR AENEX AESAV AFFZL AFGWE AFLYV AFRAH AFVBQ AGORE AGQPQ AGQXC AHGBF AHGCF AHGXI AJBYB AJEEA AJNCP ALMA_UNASSIGNED_HOLDINGS ALSGL ALXQX ANBJS ANLMG ANUXI APEMP ASKNT ASPBG ATGXG AUDPV AVWKF AZFZN BCRHZ BEYMZ BSQNT C6K CAG CGR COF CUY CVF DU5 EBS ECM EE0 EF- EIF EJD F5P FEDTE FLUFQ FOEOM H13 HVGLF HZ~ H~N J3G J3H J3I JXSIZ KBUDW KOP KSI KSN L-8 M4U N9A NOMLY NPM NU- O-G O9- OBOKY OJZSN OK1 OWPYF R56 RCNCU RNS ROX RPMJG RSCEA VUG 7X8 |
| ID | FETCH-LOGICAL-c323t-11b51f3b820babf9bb46be624b3472415a672448b4976338f22269fab12b2042 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 86 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000318304100014&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1756-591X |
| IngestDate | Sun Sep 28 12:35:58 EDT 2025 Mon Jul 21 05:41:20 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c323t-11b51f3b820babf9bb46be624b3472415a672448b4976338f22269fab12b2042 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://academic.oup.com/metallomics/article-pdf/5/5/514/34752082/c3mt20252f.pdf |
| PMID | 23487034 |
| PQID | 1348500641 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1348500641 pubmed_primary_23487034 |
| PublicationCentury | 2000 |
| PublicationDate | 2013-05-00 |
| PublicationDateYYYYMMDD | 2013-05-01 |
| PublicationDate_xml | – month: 05 year: 2013 text: 2013-05-00 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Metallomics |
| PublicationTitleAlternate | Metallomics |
| PublicationYear | 2013 |
| SSID | ssj0064005 |
| Score | 2.3013833 |
| Snippet | Cisplatin and some of its derivatives have been shown to be very successful anticancer agents. Their main mode of action has been proposed to be via covalent... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 514 |
| SubjectTerms | Animals Cattle Cell Cycle - drug effects Cell Death - drug effects Cell Line, Tumor Chemical Precipitation Cisplatin - chemistry Cisplatin - pharmacology DNA - metabolism Humans Inhibitory Concentration 50 Mice Molecular Docking Simulation NIH 3T3 Cells Organoplatinum Compounds - chemistry Organoplatinum Compounds - metabolism Organoplatinum Compounds - pharmacology Phagocytosis - drug effects Platinum - chemistry Platinum - metabolism Platinum - pharmacology |
| Title | A platinum complex that binds non-covalently to DNA and induces cell death via a different mechanism than cisplatin |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/23487034 https://www.proquest.com/docview/1348500641 |
| Volume | 5 |
| WOSCitedRecordID | wos000318304100014&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3JTuQwELUY4DAXlmHfVCMhbhbyluWEWiziAC0OCPWt5Yod0RJJGhIQ_D1ldxpOSCPNJTlYSRznpepVuezH2HEqvbMWE-5QOK5zrXhmHfJUOWs0MXaM-ikPN-lwmI1G-V2fcGv7ssq5TYyG2jVFyJGfCqUzExyoOJs-86AaFWZXewmNX2xJEZUJqE5HX7MICeHTxAWRJuEmF6P59qQqPy1U1VHcb2T5M7WMLuZq9X87t8ZWenIJgxka1tmCr_-wjUFNgXX1AScQyz1jHn2DtQOYhjq4-rWCWFfu36F7tB1QqOxaqJuaFw3BkJzS0wd0DVwMB2BrB9RMcGghpPzBBQYJbxMLFuZaKx1UPqwnnrRVuGMNxaSdPWqT3V9d3p9f816BgRdKqo4LgUaUCokmoMUyR9QJ-kRqVDoNvt8mdNIZamI1FOyWxDaSvLQoJEoyB1tskbrrdxhoWyojbJr5VGsvMC-1CcGlsD6XErNd9nc-smMCeHgFW_vmtR1_j-0u2559nvF0thPHWFIbmSy99w9X77PfMkpZhGLFA7ZU0u_tD9ly8dZN2pejiBw6Du9uPwEQkc6A |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+platinum+complex+that+binds+non-covalently+to+DNA+and+induces+cell+death+via+a+different+mechanism+than+cisplatin&rft.jtitle=Metallomics&rft.au=Suntharalingam%2C+Kogularamanan&rft.au=Mendoza%2C+Oscar&rft.au=Duarte%2C+Alexandra+A&rft.au=Mann%2C+David+J&rft.date=2013-05-01&rft.eissn=1756-591X&rft.volume=5&rft.issue=5&rft.spage=514&rft_id=info:doi/10.1039%2Fc3mt20252f&rft_id=info%3Apmid%2F23487034&rft_id=info%3Apmid%2F23487034&rft.externalDocID=23487034 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1756-591X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1756-591X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1756-591X&client=summon |